The IL-23/IL-17 pathway in human chronic inflammatory diseases-new insight from genetics and targeted therapies.

Bianchi E, Rogge L

Open source

DOI
10.1038/s41435-019-0067-y
Published
2019 May
Container
Genes and immunity
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41435-019-0067-y,
  title = {The IL-23/IL-17 pathway in human chronic inflammatory diseases-new insight from genetics and targeted therapies.},
  author = {Bianchi E and Rogge L},
  year = {2019},
  journal = {Genes and immunity},
  doi = {10.1038/s41435-019-0067-y},
  url = {https://doi.org/10.1038/s41435-019-0067-y}
}

RIS

TY  - JOUR
TI  - The IL-23/IL-17 pathway in human chronic inflammatory diseases-new insight from genetics and targeted therapies.
AU  - Bianchi E
AU  - Rogge L
PY  - 2019
JO  - Genes and immunity
DO  - 10.1038/s41435-019-0067-y
UR  - https://doi.org/10.1038/s41435-019-0067-y
ER  - 

APA

E, B., & L, R. (2019). The IL-23/IL-17 pathway in human chronic inflammatory diseases-new insight from genetics and targeted therapies.. Genes and immunity. https://doi.org/10.1038/s41435-019-0067-y

Source records